Roivant Sciences
ROIV
318 hedge funds and large institutions have $6.65B invested in Roivant Sciences in 2024 Q4 according to their latest regulatory filings, with 69 funds opening new positions, 94 increasing their positions, 103 reducing their positions, and 41 closing their positions.
68% more first-time investments, than exits
New positions opened: 69 | Existing positions closed: 41
9% more funds holding
Funds holding: 293 → 318 (+25)
1% more capital invested
Capital invested by funds: $6.57B → $6.65B (+$86.7M)
0.32% more ownership
Funds ownership: 76.97% → 77.28% (+0.32%)
0% more funds holding in top 10
Funds holding in top 10: 17 → 17 (0)
9% less repeat investments, than reductions
Existing positions increased: 94 | Existing positions reduced: 103
14% less call options, than puts
Call options by funds: $9.58M | Put options by funds: $11.1M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$58.4M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$56.5M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$37.4M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$28.4M |
| 5 |
TCIM
TOMS Capital Investment Management
New York
|
+$22.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Viking Global Investors
Stamford,
Connecticut
|
-$74.4M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$48.8M |
| 3 |
SIAU
SB Investment Advisers (UK)
London,
United Kingdom
|
-$45.8M |
| 4 |
Goldman Sachs
New York
|
-$38.8M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$30.2M |
ROIV Hedge Fund Activity: Q4 2024 in Review
318 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Roivant Sciences (ROIV) for Q4 2024, worth a combined $6.65B — up 1.3% from $6.57B a quarter earlier.
Buyers outnumbered sellers: 69 funds opened new ROIV positions and 41 closed out — a net gain of 28 holders — while 94 added to existing stakes and 103 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $58.4M. The largest seller was Viking Global Investors, cutting an estimated $74.4M.
- 318 institutional investors held Roivant Sciences (ROIV) as of Q4 2024, up from 293 in Q3 2024.
- Funds reported $6.65B of Roivant Sciences stock for Q4 2024, up 1.3% quarter-over-quarter.
- 69 funds opened new Roivant Sciences positions in Q4 2024 and 41 closed out, a net change of +28 holders.
- The largest Roivant Sciences buyer in Q4 2024 was Morgan Stanley, an estimated $58.4M added.
- The largest Roivant Sciences seller in Q4 2024 was Viking Global Investors, an estimated $74.4M sold.
Based on aggregated 13F filings for Q4 2024.